SS
IMCR icon

SBI Securities’s Immunocore IMCR Stock Holding History

SBI Securities’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.27K Hold
103
– – ﹤0.01% 2365
2026
Q1 		$3.1K Hold
103
– – ﹤0.01% 2240
2025
Q4 		$3.58K Hold
103
– – ﹤0.01% 2160
2025
Q3 		$3.74K Sell
103
-3
-3% -$102 ﹤0.01% 2167
2025
Q2 		$3.33K Sell
106
-3
-3% -$93 ﹤0.01% 2178
2025
Q1 		$3.23K Hold
109
– – ﹤0.01% 2072
2024
Q4 		$3.22K Buy
+109
New +$3.45K ﹤0.01% 2101

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

SBI Securities's IMCR Position: Q2 2026 in Review

SBI Securities held its Immunocore (IMCR) position steady in Q2 2026 at 103 shares worth $3.27K. The position accounts for ﹤0.01% of the portfolio, ranked #2365.

SBI Securities first reported a position in IMCR in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.74K in Q3 2025. 135 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • SBI Securities held 103 shares of Immunocore worth $3.27K as of Q2 2026.
  • SBI Securities left its Immunocore share count unchanged in Q2 2026.
  • Immunocore made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2365 holding.
  • SBI Securities first reported a position in Immunocore in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Immunocore position peaked at $3.74K in Q3 2025.
  • 135 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.